These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 15648014)

  • 1. The myopathy of statins.
    Smogorzewski M
    J Ren Nutr; 2005 Jan; 15(1):87-93. PubMed ID: 15648014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of mitochondria in statin-induced myopathy.
    Apostolopoulou M; Corsini A; Roden M
    Eur J Clin Invest; 2015 Jul; 45(7):745-54. PubMed ID: 25991405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statin-induced myopathies.
    Tomaszewski M; Stępień KM; Tomaszewska J; Czuczwar SJ
    Pharmacol Rep; 2011; 63(4):859-66. PubMed ID: 22001973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategies for the prevention and treatment of statin-induced myopathy: is there a role for ubiquinone supplementation?
    Koumis T; Nathan JP; Rosenberg JM; Cicero LA
    Am J Health Syst Pharm; 2004 Mar; 61(5):515-9. PubMed ID: 15018231
    [No Abstract]   [Full Text] [Related]  

  • 5. Risk factors and drug interactions predisposing to statin-induced myopathy: implications for risk assessment, prevention and treatment.
    Chatzizisis YS; Koskinas KC; Misirli G; Vaklavas C; Hatzitolios A; Giannoglou GD
    Drug Saf; 2010 Mar; 33(3):171-87. PubMed ID: 20158283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Muscle problems due to statins: underestimated].
    Janssen SP; Smulders YM; Gerdes VE; Visseren FL
    Ned Tijdschr Geneeskd; 2010; 154():A1684. PubMed ID: 21435278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms and assessment of statin-related muscular adverse effects.
    Moßhammer D; Schaeffeler E; Schwab M; Mörike K
    Br J Clin Pharmacol; 2014 Sep; 78(3):454-66. PubMed ID: 25069381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The broad spectrum of statin myopathy: from myalgia to rhabdomyolysis.
    Harper CR; Jacobson TA
    Curr Opin Lipidol; 2007 Aug; 18(4):401-8. PubMed ID: 17620856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statin myopathy.
    Radcliffe KA; Campbell WW
    Curr Neurol Neurosci Rep; 2008 Jan; 8(1):66-72. PubMed ID: 18367041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current overview of statin-induced myopathy.
    Rosenson RS
    Am J Med; 2004 Mar; 116(6):408-16. PubMed ID: 15006590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multistate transition model for statin-induced myopathy and statin discontinuation.
    Zhu Y; Chiang CW; Wang L; Brock G; Milks MW; Cao W; Zhang P; Zeng D; Donneyong M; Li L
    CPT Pharmacometrics Syst Pharmacol; 2021 Oct; 10(10):1236-1244. PubMed ID: 34562311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statin Toxicity.
    Ward NC; Watts GF; Eckel RH
    Circ Res; 2019 Jan; 124(2):328-350. PubMed ID: 30653440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coenzyme Q10 and statin-related myopathy.
    Drug Ther Bull; 2015 May; 53(5):54-6. PubMed ID: 25977402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-drug interactions that interfere with statin metabolism.
    Hirota T; Ieiri I
    Expert Opin Drug Metab Toxicol; 2015; 11(9):1435-47. PubMed ID: 26058399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statins and myotoxicity: a therapeutic limitation.
    Tiwari A; Bansal V; Chugh A; Mookhtiar K
    Expert Opin Drug Saf; 2006 Sep; 5(5):651-66. PubMed ID: 16907655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statin-associated myopathy.
    Thompson PD; Clarkson P; Karas RH
    JAMA; 2003 Apr; 289(13):1681-90. PubMed ID: 12672737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severity of statin-induced adverse effects on muscle and associated conditions: data from the DAMA study.
    Pedro-Botet J; Millán Núñez-Cortés J; Chillarón JJ; Flores-Le Roux JA; Rius J
    Expert Opin Drug Saf; 2016 Dec; 15(12):1583-1587. PubMed ID: 27645494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antilipemic therapy and rhabdomyolysis].
    Paragh G; Balogh Z; Romics L
    Orv Hetil; 2003 Mar; 144(11):515-20. PubMed ID: 12731338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidative stress as a possible mechanism of statin-induced myopathy.
    Ahmadi Y; Ghorbanihaghjo A; Naghi-Zadeh M; Yagin NL
    Inflammopharmacology; 2018 Jun; 26(3):667-674. PubMed ID: 29574631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statin myopathy as a metabolic muscle disease.
    Phillips PS; Haas RH
    Expert Rev Cardiovasc Ther; 2008 Aug; 6(7):971-8. PubMed ID: 18666847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.